Loading…
Reported covered position: Senior Legislative Asst., Cong. Earl Pomeroy
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Grown in America Act of 2025
Client: ANHEUSER-BUSCH COMPANIES INC · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
- Proposals related to corporate tax issues, legislation regarding ag/domestic manufacturing, and alcohol related tax policies - HR 1707/Grown in America Act
Secure Family Futures Act of 2023
Client: PRUDENTIAL FINANCIAL INC · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Tax issues related to the life insurance industry H.R. 5707 Proposals relating to 403b
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
INVESTMENT COMPANY INSTITUTE via PUBLIC STRATEGIES WASHINGTON, INC.
2025 · first_quarter · 1@
Issues related to the regulation of asset managers Issues related to the electronic delivery of investor materials Monitoring proposals related to U.S.-China relationship Proposals related to ESG disclosures Monitoring proposals related to fiduciary rule
Issues relating to retirement security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| CLEVELAND CLINIC FOUNDATION |
| 15 |
| 2021–2023 |
| NOVO NORDISK, INC. | 14 | 2022–2025 |
| AMGEN | 10 | 2020–2021 |
| BRISTOL-MYERS SQUIBB | 8 | 2020–2021 |
| MERCK & CO., INC. | 5 | 2020 |
| BAUSCH HEALTH COMPANIES, INC. | 3 | 2021 |
Secure Family Futures Act of 2023
Client: PRUDENTIAL FINANCIAL INC · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Tax issues related to the life insurance industry H.R. 5707 Proposals relating to 403b
Secure Family Futures Act of 2023
Client: PRUDENTIAL FINANCIAL INC · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Tax issues related to the life insurance industry H.R. 5707 Proposals relating to 403b
Secure Family Futures Act of 2023
Client: PRUDENTIAL FINANCIAL INC · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Tax issues related to the life insurance industry Ongoing monitoring of the consideration of legislative proposals related to paid family and medical leave H.R. 5707
Elijah E. Cummings Lower Drug Costs Now Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals (H.R. 3). Issues relating to biologics and biosimilars in Medicare and generally.
Elijah E. Cummings Lower Drug Costs Now Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals (H.R. 3) Issues relating to biologics and biosimilars in Medicare and generally.
Elijah E. Cummings Lower Drug Costs Now Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals (H.R. 3). Issues relating to biologics and biosimilars in Medicare and generally.
Elijah E. Cummings Lower Drug Costs Now Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals (H.R. 3) Issues relating to biologics and biosimilars in Medicare and generally.
Elijah E. Cummings Lower Drug Costs Now Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals (H.R. 3). Issues relating to biologics and biosimilars in Medicare and generally.
Elijah E. Cummings Lower Drug Costs Now Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals (H.R. 3) Issues relating to biologics and biosimilars in Medicare and generally.
Elijah E. Cummings Lower Drug Costs Now Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals (H.R. 3) Issues relating to biologics and biosimilars in Medicare and generally.
Elijah E. Cummings Lower Drug Costs Now Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals (H.R. 3). Issues relating to biologics and biosimilars in Medicare and generally.
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMGEN · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals (H.R. 3) Issues relating to biologics and biosimilars in Medicare and generally.
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMGEN · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals (H.R. 3) Issues relating to biologics and biosimilars in Medicare and generally.
Elijah E. Cummings Lower Drug Costs Now Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals (H.R. 3). Issues relating to biologics and biosimilars in Medicare and generally.
Elijah E. Cummings Lower Drug Costs Now Act
Client: BRISTOL-MYERS SQUIBB · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Legislative proposals impacting the prescription drug industry including H.R. 3
Elijah E. Cummings Lower Drug Costs Now Act
Client: AMGEN · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals (H.R. 3) Issues relating to biologics and biosimilars in Medicare and generally.
Elijah E. Cummings Lower Drug Costs Now Act
Client: BRISTOL-MYERS SQUIBB · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals and H.R. 3. Issues relating to biologics and biosimilars in Medicare and generally.
Elijah E. Cummings Lower Drug Costs Now Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals (H.R. 3) Issues relating to biologics and biosimilars in Medicare and generally.
Elijah E. Cummings Lower Drug Costs Now Act
Client: BRISTOL-MYERS SQUIBB · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Legislative proposals impacting the prescription drug industry including H.R. 3
Elijah E. Cummings Lower Drug Costs Now Act
Client: BRISTOL-MYERS SQUIBB · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Legislative proposals impacting the prescription drug industry including H.R. 3
Elijah E. Cummings Lower Drug Costs Now Act
Client: BRISTOL-MYERS SQUIBB · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Legislative proposals impacting the prescription drug industry including H.R. 3
Elijah E. Cummings Lower Drug Costs Now Act
Client: BRISTOL-MYERS SQUIBB · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals and H.R. 3. Issues relating to biologics and biosimilars in Medicare and generally. Provisions in the American Rescue Plan relating to pharmaceutical supply chain, and vaccine and therapeutic development/reimbursement.
Elijah E. Cummings Lower Drug Costs Now Act
Client: BRISTOL-MYERS SQUIBB · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals and H.R. 3.
Elijah E. Cummings Lower Drug Costs Now Act
Client: BRISTOL-MYERS SQUIBB · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals and H.R. 3.
Elijah E. Cummings Lower Drug Costs Now Act
Client: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals (H.R. 3). Issues relating to biologics and biosimilars in Medicare and generally.
Elijah E. Cummings Lower Drug Costs Now Act
Client: BIOTECHNOLOGY INDUSTRY ORGANIZATION · Firm: PUBLIC STRATEGIES WASHINGTON, INC.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals (H.R. 3) Issues relating to biologics and biosimilars in Medicare and generally.
INVESTMENT COMPANY INSTITUTE via PUBLIC STRATEGIES WASHINGTON, INC.
2025 · first_quarter · 1T
Issues related to the regulation of asset managers Issues related to the electronic delivery of investor materials Monitoring proposals related to U.S.-China relationship Proposals related to ESG disclosures Monitoring proposals related to fiduciary rule
Issues relating to retirement security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRUDENTIAL FINANCIAL INC via PUBLIC STRATEGIES WASHINGTON, INC.
2025 · first_quarter · Q1
Tax issues related to the life insurance industry Proposals related to ordinary tax treatment of debt investments Proposals relating to 403b
Issues relating to retirement security Legislation to enhance retirement plan options Monitor legislation related to data privacy and security
Proposals related to ESG disclosures Monitoring issues related to U.S.-China relationship Proposals related to the fiduciary rule
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRINCIPAL FINANCIAL GROUP via PUBLIC STRATEGIES WASHINGTON, INC.
2025 · first_quarter · Q1
Issues relating to retirement security
Ongoing monitoring of legislative proposals related to paid family and medical leave Monitoring issues related to U.S.-China relationship
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via PUBLIC STRATEGIES WASHINGTON, INC.
2025 · first_quarter · Q1
Issues related to the coverage of obesity therapeutics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVESTMENT COMPANY INSTITUTE via PUBLIC STRATEGIES WASHINGTON, INC.
2025 · first_quarter · Q1
Issues related to the regulation of asset managers Issues related to the electronic delivery of investor materials Monitoring proposals related to U.S.-China relationship Proposals related to ESG disclosures Monitoring proposals related to fiduciary rule
Issues relating to retirement security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANHEUSER-BUSCH COMPANIES INC via PUBLIC STRATEGIES WASHINGTON, INC.
2025 · first_quarter · Q1
- Proposals related to corporate tax issues, legislation regarding ag/domestic manufacturing, and alcohol related tax policies - HR 1707/Grown in America Act
Monitor international trade and tariff activity
Differentiation of beer and liquor in tax and regulations
ANHEUSER-BUSCH COMPANIES INC via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · fourth_quarter · Q4
Monitor international trade and tariff activity
Issues relating to the dietary guidelines review process
Proposals related to corporate tax issues, legislation regarding ag/domestic manufacturing, and alcohol related tax policies
PRUDENTIAL FINANCIAL INC via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · fourth_quarter · Q4
Issues relating to retirement security Legislation to enhance retirement plan options Monitor legislation related to data privacy and security
Tax issues related to the life insurance industry H.R. 5707 Proposals relating to 403b
Proposals related to ESG disclosures Monitoring issues related to U.S.-China relationship Proposals related to the fiduciary rule
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRINCIPAL FINANCIAL GROUP via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · fourth_quarter · Q4
Issues relating to retirement security
Ongoing monitoring of legislative proposals related to paid family and medical leave Monitoring issues related to U.S.-China relationship
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · fourth_quarter · Q4
Issues related to the coverage of obesity therapeutics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVESTMENT COMPANY INSTITUTE via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · fourth_quarter · Q4
Issues relating to retirement security
Issues related to the regulation of asset managers Issues related to the electronic delivery of investor materials Monitoring proposals related to U.S.-China relationship Proposals related to ESG disclosures Monitoring proposals related to fiduciary rule
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · fourth_quarter · 4T
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally Issues relating to biologics and biosimilars in Medicare and generally.
Monitor legislative proposals relating to data privacy and security
Issues relating to tax provisions covering the pharmaceutical and biologic industries.
PRUDENTIAL FINANCIAL INC via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · third_quarter · Q3
Proposals related to ESG disclosures Monitoring issues related to U.S.-China relationship Proposals related to the fiduciary rule
Tax issues related to the life insurance industry H.R. 5707 Proposals relating to 403b
Issues relating to retirement security Legislation to enhance retirement plan options Monitor legislation related to data privacy and security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRINCIPAL FINANCIAL GROUP via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · third_quarter · Q3
Ongoing monitoring of legislative proposals related to paid family and medical leave Monitoring issues related to U.S.-China relationship
Issues relating to retirement security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · third_quarter · Q3
Issues related to the coverage of obesity therapeutics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVESTMENT COMPANY INSTITUTE via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · third_quarter · Q3
Issues related to the regulation of asset managers Issues related to the electronic delivery of investor materials Monitoring proposals related to U.S.-China relationship Proposals related to ESG disclosures Monitoring proposals related to fiduciary rule
Issues relating to retirement security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · third_quarter · Q3
Issues relating to tax provisions covering the pharmaceutical and biologic industries.
Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property.
Monitor legislative proposals relating to data privacy and security
ANHEUSER-BUSCH COMPANIES INC via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · third_quarter · Q3
Proposals related to corporate tax issues, legislation regarding ag/domestic manufacturing, and alcohol related tax policies
Monitor international trade and tariff activity
Issues relating to the dietary guidelines review process
PRUDENTIAL FINANCIAL INC via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · second_quarter · Q2
Issues relating to retirement security Legislation to enhance retirement plan options Monitor legislation related to data privacy and security
Tax issues related to the life insurance industry H.R. 5707 Proposals relating to 403b
Proposals related to ESG disclosures Monitoring issues related to U.S.-China relationship Proposals related to the fiduciary rule
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRINCIPAL FINANCIAL GROUP via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · second_quarter · Q2
Issues relating to retirement security
Ongoing monitoring of legislative proposals related to paid family and medical leave Monitoring issues related to U.S.-China relationship
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · second_quarter · Q2
Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property.
Monitor legislative proposals relating to data privacy and security
Issues relating to tax provisions covering the pharmaceutical and biologic industries.
NOVO NORDISK INC. via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · second_quarter · Q2
Issues related to the coverage of obesity therapeutics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVESTMENT COMPANY INSTITUTE via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · second_quarter · Q2
Issues relating to retirement security
Issues related to the regulation of asset managers Issues related to the electronic delivery of investor materials Monitoring proposals related to U.S.-China relationship Proposals related to ESG disclosures Monitoring proposals related to fiduciary rule
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANHEUSER-BUSCH COMPANIES INC via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · second_quarter · Q2
Differentiation of beer and liquor in tax and regulations
Proposals related to corporate tax issues, legislation regarding ag/domestic manufacturing, and alcohol related tax policies
Monitor international trade and tariff activity
BIOTECHNOLOGY INDUSTRY ORGANIZATION via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · second_quarter · Q2
Monitor legislative proposals relating to data privacy and security
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally Issues relating to biologics and biosimilars in Medicare and generally.
Issues relating to tax provisions covering the pharmaceutical and biologic industries.
PRUDENTIAL FINANCIAL INC via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · first_quarter · Q1
Issues relating to retirement security Legislation to enhance retirement plan options Monitor legislation related to data privacy and security
Proposals related to ESG disclosures Monitoring issues related to U.S.-China relationship Proposals related to the fiduciary rule
Tax issues related to the life insurance industry Ongoing monitoring of the consideration of legislative proposals related to paid family and medical leave H.R. 5707
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRINCIPAL FINANCIAL GROUP via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · first_quarter · Q1
Ongoing monitoring of legislative proposals related to paid family and medical leave Monitoring issues related to U.S.-China relationship
Issues relating to retirement security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · first_quarter · Q1
Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property.
Monitor legislative proposals relating to data privacy and security
Issues relating to tax provisions covering the pharmaceutical and biologic industries.
NOVO NORDISK INC. via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · first_quarter · Q1
Issues related to the coverage of obesity therapeutics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVESTMENT COMPANY INSTITUTE via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · first_quarter · Q1
Issues relating to retirement security
Issues related to the regulation of asset managers Issues related to the electronic delivery of investor materials Monitoring proposals related to U.S.-China relationship Proposals related to ESG disclosures Monitoring proposals related to fiduciary rule
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · first_quarter · Q1
Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property.
Monitor legislative proposals relating to data privacy and security
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally Issues relating to biologics and biosimilars in Medicare and generally.
ANHEUSER-BUSCH COMPANIES INC via PUBLIC STRATEGIES WASHINGTON, INC.
2024 · first_quarter · Q1
Issues related to competition policy
Monitor international trade and tariff activity
Proposals related to corporate tax issues and alcohol related tax policies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRUDENTIAL FINANCIAL INC via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · fourth_quarter · 4A
Proposals related to ESG disclosures Monitoring issues related to U.S.-China relationship Proposals related to the fiduciary rule
Issues relating to retirement security Legislation to enhance retirement plan options Monitor legislation related to data privacy and security
Tax issues related to the life insurance industry Ongoing monitoring of the consideration of legislative proposals related to paid family and medical leave
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRINCIPAL FINANCIAL GROUP via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · fourth_quarter · 4A
Ongoing monitoring of legislative proposals related to paid family and medical leave Monitoring issues related to U.S.-China relationship
Issues relating to retirement security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · fourth_quarter · 4A
Issues relating to tax provisions covering the pharmaceutical and biologic industries.
Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property.
Monitor legislative proposals relating to data privacy and security
NOVO NORDISK INC. via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · fourth_quarter · 4A
Issues related to the coverage of obesity therapeutics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVESTMENT COMPANY INSTITUTE via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · fourth_quarter · 4A
Issues relating to retirement security
Issues related to the regulation of asset managers Issues related to the electronic delivery of investor materials Monitoring proposals related to U.S.-China relationship Proposals related to ESG disclosures Monitoring proposals related to fiduciary rule
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CLEVELAND CLINIC FOUNDATION via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · fourth_quarter · 4A
Monitor legislative proposals related to physician payments and other healthcare issues
FY24 Appropriations
Monitor issues related to nutrition provisions in the 2023 Farm Bill
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · fourth_quarter · 4A
Monitor legislative proposals relating to data privacy and security
Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally Issues relating to biologics and biosimilars in Medicare and generally.
ANHEUSER-BUSCH COMPANIES INC via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · fourth_quarter · 4A
Issues related to competition policy
Proposals related to corporate tax issues and alcohol related tax policies
Monitor international trade and tariff activity
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
PRUDENTIAL FINANCIAL INC via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · fourth_quarter · Q4
Issues relating to retirement security Legislation to enhance retirement plan options Monitor legislation related to data privacy and security
Proposals related to ESG disclosures Monitoring issues related to U.S.-China relationship Proposals related to the fiduciary rule
Tax issues related to the life insurance industry Ongoing monitoring of the consideration of legislative proposals related to paid family and medical leave
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRINCIPAL FINANCIAL GROUP via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · fourth_quarter · Q4
Issues relating to retirement security
Ongoing monitoring of legislative proposals related to paid family and medical leave Monitoring issues related to U.S.-China relationship
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · fourth_quarter · Q4
Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property.
Issues relating to tax provisions covering the pharmaceutical and biologic industries.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally Issues relating to biologics and biosimilars in Medicare and generally.
NOVO NORDISK INC. via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · fourth_quarter · Q4
Issues related to the coverage of obesity therapeutics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVESTMENT COMPANY INSTITUTE via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · fourth_quarter · Q4
Issues related to the regulation of asset managers Issues related to the electronic delivery of investor materials Monitoring proposals related to U.S.-China relationship Proposals related to ESG disclosures Monitoring proposals related to fiduciary rule
Issues relating to retirement security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CLEVELAND CLINIC FOUNDATION via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · fourth_quarter · Q4
Monitor legislative proposals related to physician payments and other healthcare issues
Monitor issues related to nutrition provisions in the 2023 Farm Bill
FY24 Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · fourth_quarter · Q4
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally Issues relating to biologics and biosimilars in Medicare and generally.
Issues relating to tax provisions covering the pharmaceutical and biologic industries.
Monitor legislative proposals relating to data privacy and security
ANHEUSER-BUSCH COMPANIES INC via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · fourth_quarter · Q4
Monitor international trade and tariff activity
Issues related to competition policy
Proposals related to corporate tax issues and alcohol related tax policies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
PRUDENTIAL FINANCIAL INC via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · third_quarter · Q3
Issues relating to retirement security Legislation to enhance retirement plan options Monitor legislation related to data privacy and security
Tax issues related to the life insurance industry Ongoing monitoring of the consideration of legislative proposals related to paid family and medical leave
Proposals related to ESG disclosures Monitoring issues related to U.S.-China relationship
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRINCIPAL FINANCIAL GROUP via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · third_quarter · Q3
Issues relating to retirement security
Ongoing monitoring of legislative proposals related to paid family and medical leave Monitoring issues related to U.S.-China relationship
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · third_quarter · Q3
Monitor legislative proposals relating to data privacy and security
Issues relating to tax provisions covering the pharmaceutical and biologic industries.
Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property.
NOVO NORDISK INC. via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · third_quarter · Q3
Issues related to the coverage of obesity therapeutics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVESTMENT COMPANY INSTITUTE via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · third_quarter · Q3
Issues related to the regulation of asset managers Monitoring issues related to U.S.-China relationship Proposals related to ESG disclosures
Issues relating to retirement security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CLEVELAND CLINIC FOUNDATION via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · third_quarter · Q3
FY24 Appropriations
Issues related to nutrition provisions in the 2023 Farm Bill
Issues related to physician payments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · third_quarter · Q3
Issues relating to tax provisions covering the pharmaceutical and biologic industries.
Monitor legislative proposals relating to data privacy and security
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally Issues relating to biologics and biosimilars in Medicare and generally.
ANHEUSER-BUSCH COMPANIES INC via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · third_quarter · Q3
Monitor international trade and tariff activity
Issues related to competition policy
FY24 Appropriations
PRUDENTIAL FINANCIAL INC via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · second_quarter · Q2
Proposals related to ESG disclosures Monitoring issues related to U.S.-China relationship
Issues relating to retirement security Legislation to enhance retirement plan options Monitor legislation related to data privacy and security
Tax issues related to the life insurance industry Ongoing monitoring of the consideration of legislative proposals related to paid family and medical leave
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRINCIPAL FINANCIAL GROUP via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · second_quarter · Q2
Issues relating to retirement security
Ongoing monitoring of legislative proposals related to paid family and medical leave Monitoring issues related to U.S.-China relationship
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · second_quarter · Q2
Monitor legislative proposals relating to data privacy and security
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally Issues relating to biologics and biosimilars in Medicare and generally.
Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property.
NOVO NORDISK INC. via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · second_quarter · Q2
Issues related to the coverage of obesity therapeutics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · second_quarter · Q2
Issues related to the coverage of obesity therapeutics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVESTMENT COMPANY INSTITUTE via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · second_quarter · Q2
Issues relating to retirement security
Issues related to the regulation of asset managers Issues related to the electronic delivery of investor materials Monitoring issues related to U.S.-China relationship Proposals related to ESG disclosures
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CLEVELAND CLINIC FOUNDATION via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · second_quarter · Q2
Issues related to nutrition provisions in the 2023 Farm Bill
FY24 Appropriations
Issues related to physician payments, public health emergency
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · second_quarter · Q2
Issues relating to tax provisions covering the pharmaceutical and biologic industries.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally Issues relating to biologics and biosimilars in Medicare and generally.
Monitor legislative proposals relating to data privacy and security
ANHEUSER-BUSCH COMPANIES INC via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · second_quarter · Q2
Issues related to competition policy
Proposals related to corporate tax issues and alcohol related tax policies
FY24 Appropriations
PRUDENTIAL FINANCIAL INC via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · first_quarter · Q1
Proposals related to ESG disclosures Monitoring issues related to U.S.-China relationship
Issues relating to retirement security Legislation to enhance retirement plan options Monitor legislation related to data privacy and security
Tax issues related to the life insurance industry Ongoing monitoring of the consideration of legislative proposals related to paid family and medical leave
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRINCIPAL FINANCIAL GROUP via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · first_quarter · Q1
Issues relating to retirement security
Ongoing monitoring of legislative proposals related to paid family and medical leave Monitoring issues related to U.S.-China relationship
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · first_quarter · Q1
Monitor legislative proposals relating to data privacy and security
Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally Issues relating to biologics and biosimilars in Medicare and generally.
NOVO NORDISK INC. via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · first_quarter · Q1
Issues related to the coverage of obesity therapeutics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVESTMENT COMPANY INSTITUTE via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · first_quarter · Q1
Issues related to the regulation of asset managers Issues related to the electronic delivery of investor materials Monitoring issues related to U.S.-China relationship Proposals related to ESG disclosures
Issues relating to retirement security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CLEVELAND CLINIC FOUNDATION via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · first_quarter · 1A
Issues related to physician payments, cybersecurity, public health emergency Issues related to Brain Health Study
FY24 Appropriations
Issues related to nutrition provisions in the 2023 Farm Bill
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
CLEVELAND CLINIC FOUNDATION via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · first_quarter · Q1
FY24 Appropriations
Issues related to physician payments, telehealth, infectious disease prevention research Issues related to Brain Health Study
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · first_quarter · Q1
Issues relating to tax provisions covering the pharmaceutical and biologic industries.
Monitor legislative proposals relating to data privacy and security
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally Issues relating to biologics and biosimilars in Medicare and generally.
ANHEUSER-BUSCH COMPANIES INC via PUBLIC STRATEGIES WASHINGTON, INC.
2023 · first_quarter · Q1
Issues related to competition policy
FY24 Appropriations
Monitor international trade and tariff activity
ANHEUSER-BUSCH COMPANIES INC via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · fourth_quarter · Q4
Proposals relating to corporate tax issues and alcohol tax related policies
Issues related to competition policy
Monitor international trade and tariff activity
PRUDENTIAL FINANCIAL INC via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · fourth_quarter · Q4
Issues relating to retirement security and proposals to enhance and improve retirement savings. Legislation to enhance retirement plan options. Monitor legislative proposals relating to data privacy and security
Tax issues related to the life insurance industry. Ongoing monitoring of legislative proposals related to paid family and medical leave.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRINCIPAL FINANCIAL GROUP via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · fourth_quarter · Q4
Issues relating to retirement security and proposals to enhance and improve retirement savings including SECURE 2.0 and proposals related to ESOPs
Ongoing monitoring of legislative proposals related to paid family and medical leave
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · fourth_quarter · Q4
Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property. Monitor legislation related to business exposure in Russia.
Issues relating to tax provisions covering the pharmaceutical and biologic industries.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally Issues relating to biologics and biosimilars in Medicare and generally.
NOVO NORDISK INC. via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · fourth_quarter · Q4
Issues related to the coverage of obesity therapeutics
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INVESTMENT COMPANY INSTITUTE via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · fourth_quarter · Q4
Issues relating to retirement security and proposals to enhance and improve retirement savings including SECURE 2.0
Issues related to the regulation of asset managers. Issues related to the electronic delivery of investor materials. Possible legislation regarding the creation of International Regulated Investment Companies (IRICs).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CLEVELAND CLINIC FOUNDATION via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · fourth_quarter · Q4
Issues related to physician payments, telehealth, infectious disease prevention research Issues related to Brain Health Study
FY23 Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · fourth_quarter · Q4
Issues relating to tax provisions covering the pharmaceutical and biologic industries.
Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property.
Monitor legislative proposals related to data privacy and security
NOVO NORDISK INC. via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · third_quarter · Q3
Issues related to the coverage of obesity therapeutics in Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · third_quarter · RR
issues related to the coverage of obesity therapeutics in Medicare
issues related to the coverage of obesity therapeutics in Medicare
PRUDENTIAL FINANCIAL INC via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · third_quarter · Q3
Issues relating to retirement security and proposals to enhance and improve retirement savings. Legislation to enhance retirement plan options. Monitor legislative proposals relating to data privacy and security in the retirement insurance industry.
Tax issues related to the life insurance industry. Ongoing monitoring of the Inflation Reduction ACt and other legislative proposals related to paid family and medical leave.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRINCIPAL FINANCIAL GROUP via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · third_quarter · Q3
Issues relating to retirement security and proposals to enhance and improve retirement savings. Legislation to enhance retirement plan options including SECURE 2.0 and proposals related to ESOPs
Tax issues related to the life insurance industry. Ongoing monitoring of the consideration of reconciliation and other legislative proposals related to paid family and medical leave
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · third_quarter · Q3
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals (H.R. 3). Issues relating to biologics and biosimilars in Medicare and generally.
Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property. Monitor legislation related to business exposure in Russia.
Issues relating to tax provisions covering the pharmaceutical and biologic industries.
INVESTMENT COMPANY INSTITUTE via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · third_quarter · Q3
Issues related to the regulation of asset managers. Issues related to the electronic delivery of investor materials. Possible legislation regarding the creation of International Regulated Investment Companies (IRICs).
Issues relating to retirement security and proposals to enhance and improve retirement savings including SECURE 2.0
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CLEVELAND CLINIC FOUNDATION via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · third_quarter · Q3
Issues relating to cybersecurity for healthcare systems, including cybersecurity for medical devices Issues related to disease prevention research
FY23 Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · third_quarter · Q3
Issues relating to tax provisions covering the pharmaceutical and biologic industries.
Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals (H.R. 3) Issues relating to biologics and biosimilars in Medicare and generally.
ANHEUSER-BUSCH COMPANIES INC via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · third_quarter · Q3
FY23 Appropriations
Proposals relating to corporate tax issues and alcohol tax related policies
Issues related to competition policy
PRUDENTIAL FINANCIAL INC via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · second_quarter · Q2
Tax issues related to the life insurance industry. Ongoing monitoring of reconciliation proposals and other legislative proposals related to paid family and medical leave.
Issues relating to retirement security and proposals to enhance and improve retirement savings. Legislation to enhance retirement plan options. Monitor legislative proposals relating to data privacy and security in the retirement insurance industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRINCIPAL FINANCIAL GROUP via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · second_quarter · Q2
Issues relating to retirement security and proposals to enhance and improve retirement savings. Legislation to enhance retirement plan options including SECURE 2.0
Tax issues related to the life insurance industry. Ongoing monitoring of the consideration of reconciliation and other legislative proposals related to paid family and medical leave
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · second_quarter · Q2
Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property. Monitor legislation related to business exposure in Russia.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals (H.R. 3). Issues relating to biologics and biosimilars in Medicare and generally.
Monitor legislative proposals relating to data privacy and security
INVESTMENT COMPANY INSTITUTE via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · second_quarter · Q2
Issues related to the regulation of asset managers. Issues related to the electronic delivery of investor materials. Possible legislation regarding the creation of International Regulated Investment Companies (IRICs).
Issues relating to retirement security and proposals to enhance and improve retirement savings including SECURE 2.0
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · second_quarter · Q2
Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property.
Issues relating to tax provisions covering the pharmaceutical and biologic industries.
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals (H.R. 3) Issues relating to biologics and biosimilars in Medicare and generally.
CLEVELAND CLINIC FOUNDATION via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · second_quarter · Q2
Issues relating to cybersecurity for healthcare systems, including cybersecurity for medical devices Issues related to the formula shortage Issues related to disease prevention research
FY23 Appropriations
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ANHEUSER-BUSCH COMPANIES INC via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · second_quarter · Q2
Monitor international trade and tariff activity
Proposals relating to corporate tax issues and alcohol tax related policies
FY23 Appropriations
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA via PUBLIC STRATEGIES WASHINGTON, INC.
2022 · first_quarter · Q1
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals (H.R. 3). Issues relating to biologics and biosimilars in Medicare and generally.
Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property.
Ongoing monitoring of the consideration of the Build Back Better Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to dietary guidelines review process
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Differentiation of beer and liquor in tax and regulations
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally Issues relating to biologics and biosimilars in Medicare and generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Differentiation of beer and liquor in tax and regulations
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally Issues relating to biologics and biosimilars in Medicare and generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to the dietary guidelines review process
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally Issues relating to biologics and biosimilars in Medicare and generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to tax provisions covering the pharmaceutical and biologic industries.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally Issues relating to biologics and biosimilars in Medicare and generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to tax provisions covering the pharmaceutical and biologic industries.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Monitor legislative proposals relating to data privacy and security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally Issues relating to biologics and biosimilars in Medicare and generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Proposals related to corporate tax issues and alcohol related tax policies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Issues relating to tax provisions covering the pharmaceutical and biologic industries.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Monitor international trade and tariff activity
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Issues relating to tax provisions covering the pharmaceutical and biologic industries.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to trade agreements regarding pharmaceutical and biologic patents and intellectual property.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Proposals related to corporate tax issues and alcohol related tax policies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
FY23 Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Monitor legislative proposals relating to data privacy and security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally Issues relating to biologics and biosimilars in Medicare and generally.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Monitor legislative proposals relating to data privacy and security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Monitor legislative proposals related to data privacy and security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Monitor international trade and tariff activity
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
Issues relating to tax provisions covering the pharmaceutical and biologic industries.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Monitor legislative proposals related to data privacy and security
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to competition policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of